Abstract: Solitary fibrous tumors (SFTs) of the head and neck are uncommon. Lesions previously diagnosed in the head and neck as hemangiopericytomas (HPCs), giant cell angiofibromas (GCAs), and orbital fibrous histiocytomas (OFHs) are now recognized as within the expanded spectrum of SFTs. To better understand the clinicopathologic profile of head and neck SFTs, we performed a multi-institutional study of 88 examples. There was no sex predilection (F:M ratio 1.2), and the median patient age was 52 years (range: 15 to above 89 y). The sinonasal tract and orbit were the most common sites involved (30% and 25%), followed by the oral cavity and salivary glands (15% and 14%). Original diagnoses included HPC (25%), SFT (67%), and OFH (6%), with 1 SFT and 1 OFH noted as showing GCA-like morphology. On review, the predominant histologic pattern was classic SFT-like in 53% and cellular (former HPC-like) in 47%; lipomatous differentiation (8%) and GCA-like pattern (7%) were less prevalent. Subsets demonstrated nuclear atypia (23%), epithelioid morphology (15%), or coagulative necrosis (6%). Infiltrative growth (49%) and osseous invasion (82%) were prevalent among evaluable cases. Of the 48 SFTs with follow-up (median: 43 mo), 19 showed recurrence (40%). Of these, 4 patients were alive with disease and 4 dead of disease. Size and mitotic rate were negative prognosticators using a joint prognostic proportional hazards regression model. Three patients experienced metastasis, to lungs, parotid, bone, and skull base, including one case showing overtly sarcomatous "dedifferentiation." As a group, SFTs present in a wide anatomic and morphologic spectrum in the head and neck. Only rare examples metastasize or cause death from disease. However, the fairly high local recurrence rate underscores their aggressive potential and highlights the importance of prospective recognition.
T he concepts of solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) have evolved significantly between their first descriptions in the pleura in 1931 1 and in various sites in 1942 2 and their unification as SFT in contemporary WHO classifications. 3, 4 The SFT spectrum of neoplasms is believed to be composed of specialized fibroblasts, arises in diverse anatomic sites, and exhibits protean histomorphology. However, the diagnosis is best made through appreciation of bland, ovoid to spindle cells haphazardly arrayed in a "patternless pattern" of varying cellular density in admixture with stromal collagen bundles and arranged around characteristic "staghorn" vasculature. The histologic spectrum has expanded with appreciation of myxoid, 5 epithelioid, 6, 7 and lipomatous [8] [9] [10] SFTs, as well as identification of cases showing atypical features 5, 11, 12 and sarcomatous dedifferentiation. 6, 13, 14 Despite the histologic diversity, recent molecular findings confirm the identity of these lesions through their shared pathognomonic genetic lesion, oncogenic fusion of the genes NAB2 and STAT6, [15] [16] [17] [18] [19] detectable by sequencing, polymerase chain reaction, fluorescence in situ hybridization among a subset, or simply by immunohistochemistry.
Prior published series suggest that classic SFTs of the head and neck represent ∼6% of all SFTs, or approximately one quarter of extrathoracic SFTs, which in turn represent one quarter of all SFTs. 12, [20] [21] [22] [23] Thus, limited data describe the biological potential of these unpredictable lesions in the distinctive clinical and anatomic milieu of the head and neck. Moreover, lesions previously designated as giant cell angiofibroma (GCA) and orbital fibrous histiocytoma (OFH) have been recently proposed to be part of the spectrum of SFTs 24 and may alter the overall anatomic distribution or prognosis. Conversely new molecular data confirm the exclusion from SFT of head and neck-specific lesions, including the true pericytic neoplasm, glomangiopericytoma or sinonasal HPC, 25, 26 which has been recently found to exhibit CTNNB1 mutation and nuclear accumulation of β-catenin. 27 In addition, the recently described, biphenotypic low-grade sinonasal sarcoma with neural and myogenic features, 28, 29 deserves mention as a newer entity outside of the SFT spectrum.
This rapid evolution of morphologic and molecular understanding in this area calls for a reassessment of the contemporary spectrum of head and neck SFTs, especially to better define their biological potential and clinical behavior. Herein, we report findings from this retrospective analysis, which consists of consecutive cases encountered over a number of years at the hospitals of the University of Michigan, the University of Pittsburgh, Cedars-Sinai Medical Center, and Virginia Commonwealth University.
METHODS

Multi-Institutional Retrospective Case Series
With Institutional Review Board approval from participating institutions, searches were performed using the laboratory information systems of the University of Michigan Health System (UMHS; 1990 to 2013) University of Pittsburgh Medical Center (UPMC; 1982 to 2015), Cedars-Sinai Medical Center (CSMC 1990 to 2014), and VCU Health System (1990 to 2014) cases diagnosed previously as SFT, HPC, GCA, and OFH. Archival slides and or tissue blocks were obtained from institutional slide libraries, and hematoxylin and eosin-stained recuts were performed if paraffin blocks were available. Consultation cases were included if material were retained and available for evaluation (predominantly, UPMC). Deidentified clinical data were tabulated, including sex, age (censored at older than 89 y), anatomic site, and follow-up status regarding local recurrence or metastasis, from the electronic medical record and pathology department files.
Histologic Review
Cases previously diagnosed as SFT, HPC, GCA, and OFH, identified by retrospective searches, were included for review if they were judged clinically to have arisen in mesenchyal tissues of the head and neck, above the clavicle. Cases clinically considered to be primary to the central nervous system were excluded from consideration, given the differing anatomic and surgical aspects. For morphologic inclusion criteria, only tumors that met the morphologic definition used by the WHO Classification of Tumors of Soft Tissue, fourth edition, as described for the entity, extrapleural solitary fibrous tumor 3 (and briefly defined for the morphologic patterns below), were included for study. All other non-SFT entities, for example, glomangiopericytoma, synovial sarcoma, and biphenotypic sinonasal sarcomas were excluded (consensus review of histology and available molecular findings by S.C.S., M.E., and J.B.M.).
Pathologic parameters tabulated included original diagnostic term, largest gross dimension, overall histologic pattern and presence or absence of atypia, lipomatous differentiation, myxoid/microcystic change, epithelioid morphology, infiltrative growth, and bone invasion, each defined below. Mitoses per 10 high power fields were counted in the most cellular areas. The overall histologic pattern was defined as "classic SFT" if the lesion showed a predominant pattern of low-to-moderate cellularity of spindle cells interspersed within a prominently collagenized matrix. Cases showing areas of focally increased cellularity were still defined as "classic SFT," if such areas were not the predominant pattern. Lesions were defined as a "cellular SFT" if the predominant histologic pattern was of a densely cellular proliferation of ovoid-to-spindled cells arrayed in a "patternless pattern" within a less prominent stroma. Atypia was defined as nuclear atypia, which included coarse chromatin, anisonucleosis, more than mild pleomorphism, and/or nuclear overlap. Any amount of unequivocal lipomatous differentiation was sufficient to consider it as present. Epithelioid morphology was defined by a pervasive pattern of round to polygonal cells with ample clear-to-pale, or eosinophilic cytoplasm and nuclei with macronucleoli; scattered foci or foci of clear cell change were excluded from this designation. Infiltrative growth was scored as present if a lesion showed even focal infiltration of perilesional adipose or soft tissue (if present for evaluation), or if a tumor showed invasion around native ductal structures (if present for evaluation). Bone invasion was considered present even if focal in cases where resected tissue included bone for evaluation. All slides were reviewed by 3 pathologists (S.C.S., M.E., J.B.M.) blinded to clinical and outcome parameters.
Immunohistochemistry
Available archived immunohistochemically (IHC)-stained slides were reviewed and tabulated if interpretable (S.C.S. and J.B.M.). For UMHS cases where archival CD34 IHC stains were not available or interpretable, IHC for CD34 was performed on selected sections in the UMHS Clinical Immunohistochemistry Core. These studies used monoclonal clone QBEnd10 (Dako, Carpenteria, CA) at 1:100 dilution after pretreatment with CC1 buffer (Dako) for 30 minutes at 95°C on a Benchmark Ultra autostainer (Ventana, Tucson, AZ). STAT6 IHC was performed on UMHS, CSMC, and VCUHS cases using an antibody to the protein C-terminus (SC-621, Santa Cruz, Biotechnology, Dallas, TX) at a 1:200 dilution using ultraView DAB detection kit (760-500; Ventana Medical Systems/Roche, Tucson, AZ) and hematoxylin counterstain on a BenchMark XT autostainer (Ventana). STAT6 IHC was performed at UPMC using rabbit monoclonal STAT6 antibody (Clone YE361; Abcam, Cambridge MA, 1:500) on a Leica Bond III. STAT6 IHC was considered positive if present in a nuclear distribution within 10% or more of lesional cells, as reported previously, 18 while CD34 IHC was scored by 
proportion of tumor cells positive as 0 (negative), 1+ (focal or multifocal), or 2+ (diffuse), both by S.C.S. and J.B.M.
Statistical Analysis
Time to disease recurrence was defined as elapsed time between diagnosis and disease recurrence. Patients without disease were censored as of their last date of follow-up or date of death if dying from a cause other than SFT. Probability of recurrence was estimated by the Kaplan-Meier method with Greenwood confidence interval. A panel of demographic, treatment-related and histologic factors were examined for effect upon time to recurrence with proportional hazards regression. A parsimonious (ie, composed of the fewest number of parameters necessary to explain the outcome) multivariate model was developed from individual covariates. Assumptions of linearity were tested for the continuous variables (tumor size, mitotic index) and the proportional hazards assumption was verified for the final model. Computations were made with the software package, R 30 using the package, rms. 31 
RESULTS
Cohorts
Database searches and histologic review of cases of SFT, HPC, OFH, and GCA resulted in a cohort of 88 cases from UMHS (n = 30, 34%), UPMC (n = 37, 42%), CSMC (n = 11, 13%), and VCUHS (n = 10, 11%). Table 1 lists clinical findings by case. Median age at diagnosis was 52 years with a range of 15 to above 89 years. The most prevalent primary site of involvement was the sinonasal tract (n = 26; 30%), of which the nasal cavities were involved in 77% (Fig. 1A) , the paranasal sinuses in 31%, and additionally the skull base in 23%. Second in prevalence to the sinonasal ones were SFTs arising primarily in the orbit (n = 22; 25%); of these, 3 extended to clinically involve the lacrimal gland (14%), while 2 eroded into the skull base (9%). Next in prevalence were tumors based in the oral cavity (n = 13, 15%), which involved buccal soft tissue in nearly half (n = 6; 46%), followed by the tongue (n = 3, 23%), palate (n = 2, 15%), and the masseter and peritonsilar soft tissues (one each). Next in prevalence were SFTs arising in the major salivary glands (n = 12; 14%), 10 of which arose in the parotid (83%), and 2 in the submandibular gland (17%). Eight tumors (9%) arose in the deep tissues of the neck, of which 4 were parapharyngeal and 1 more supraclavicular, arising in the deep musculature of the neck base, extending caudad from above the clavicle (Figs. 1B, C) . One final neck SFT arose in the periphery of the thyroid gland. Minor subsets of the SFTs were predominantly clinically documented as based in the subcutaneous soft tissues (n = 6; 7%), of which 3 involved the cheek, and 2 involved the eyelids. A single SFT arose in the external auditory canal.
Clinical Characteristics
Pathologic Characteristics Original Versus Contemporary Diagnoses
Original diagnoses included "HPC" (n = 22; 25%), "SFT" (n = 59; 67%), and OFH (n = 5; 6%). None had a topline diagnosis of GCA, though 2 cases (1% each) documented GCA-like features, one of which was originally diagnosed as an OFH and the other of which was diagnosed as a HPC. With regard to classic versus cellular morphology, there was a high degree of concordance between original diagnosis and contemporary classification, such that 19/22 (86%) of "HPCs" corresponded to cellular SFT and 39/59 (66%) cases corresponded to classic SFT, P < 0.001. Of the OFHs, 3 showed classic SFT morphology, while 2 showed cellular morphology; of the OFH and SFT with previously noted GCA-like areas, both showed classic morphology.
Gross and Microscopic Features
Head and neck SFTs were described macroscopically as circumscribed, solid, indurated, fibrous lesions, that were white, tan, or gray in color, while a case with lipomatous differentiation was softer with a "fish flesh" appearance. One SFT that demonstrated dedifferentiation into an overt high-grade sarcoma showed an infiltrative, multinodular appearance with copious necrosis described on the cut surfaces (Fig. 2) . Specimens from primary tumors ranged from 0.4 to 9.7 cm, with a median of 2.8 cm. Among recurrent lesions, the size ranged from 0.4 to 10 cm, median 4.5 cm.
Histologically, classic SFT morphology was observed more frequently (n = 47, 53%) than cellular SFT (n = 41, 47%) (Fig. 3) . Atypia, present as increased nuclear pleomorphism and/or coarseness of chromatin was present in 20 (23%), while epithelioid cytomorphology was observed in 13 (15%) (Fig. 4) . Additional morphologic variations noted included lipomatous differentiation, which was observed in 7 SFTs (8%), and stromal giant cells such as described in GCA were seen in 6 (7%) (Fig. 5) . Areas of myxoid change with cystic or microcystic morphology was noted in 6 (7%), which coincided with lipomatous differentiation in 2 of the 6. Nodular hyaline deposits reminiscent of collagen rosettes were noted in 4 (5%) (Fig. 6) , while an unusual pattern of predominant paucicellular sclerotic collagen was apparent in 1 sinonasal SFT.
Of 69 evaluable cases, infiltrative growth, defined as either an infiltrative border or as infiltration around entrapped native structures such as epithelial elements and ducts, was apparent in 34 (49%), while of SFTs where bone was included in histologic sections, 14/17 (82%) demonstrated osseous invasion. Coagulative tumor cell necrosis was noted in 5 (6%), while mitoses ranged from 0 to 18 per 10 high power fields, with a median of 1. Dedifferentiation, present as overtly malignant, undifferentiated high-grade sarcomatous transformation with frank pleomorphism and ∼50% necrosis was identified in a single SFT. Infiltrative and aggressive patterns seen are shown in Figure 7 .
Immunohistochemical stains included most frequently CD34, which was available for 80 cases, of which 41 (51%) showed strong, diffuse CD34 positivity, and a further 32 (40%) showed focal to multifocal positivity. These and additional immunohistochemical findings tabulated from re-review of archival material are summarized by Table 2 and Figure 8 . In light of recent observation of a recurrent, pathognomic NAB2-STAT6 gene fusions present in SFTs, [15] [16] [17] we performed STAT6 immunohistochemistry on all cases from CSMC and VCUHS (n = 21), and reviewed STAT6 findings for a subset of UMHS cases (n = 12) 18 and UPMC cases (n = 12). All were positive for STAT6 in a nuclear 
Recurrence-free Survival and Clinicopathologic Factors
Among the 88 patients whose pathologic characteristics were described previously, follow-up for disease recurrence was available for 48 (55%). In particular, follow-up was lacking in 24 of the 37 (65%) of patients collected at UPMC, which was related to inclusion for morphologic review of a large number of consultation cases from patients treated at outside institutions. Also, the original diagnosis of HPC was overrepresented in the followed patients, although this appears to be random variation rather than systematic. According to a recursive partitioning model, patients with follow-up differed from those without follow-up, predominately due to institutional differences. No differences were seen in variables that predicted recurrence, leading to the conclusion that analysis of factors associated with recurrence did not compromise results.
Among the 48 patients followed-up with observation (median: 77 mo, mean: 100 mo among all patients with follow up), 19 recurrences, mainly locoregional, were noted. Among the 29 patients who were disease free, the median follow-up time was 43 months (range: 0 to 274 mo). Median time to recurrence (Fig. 9 ) was 10 years, though 12/19 recurrences occurred within 2.5 years. Three patients experienced distant metastases, one of which (orbital primary site) had lung and parotid metastases. One additional patient had lung metastasis (the dedifferentiated SFT based in lower neck deep soft tissue) and additional metastases to the skull base. One final patient developed bone metastases. Six SFTs (13%) had documentation of multiple known recurrences (median: 3.5, range: 2 to 7). Four patients (8%) died of disease.
Factors associated with recurrence were investigated with proportional hazards regression (Table 3) . Size (P = 0.04, hazard ratio [HR] = 1.68), atypia (P = 0.01, HR = 3.44), mitotic rate (overall P = 0.06, HR = 1.67), necrosis (P = 0.02, HR = 4.98), and epithelioid cytomorphology (P = 0.05, HR = 2.56) were risk factors for recurrence. In an additive joint prognostic model, size (P = 0.08, HR = 1.63) and mitoses > 4 per 10 high power fields (P < 0.01, HR = 1.79) were associated with risk of recurrence (LR χ 2 = 10.64, 2df P < 0.01).
DISCUSSION
Experience with this large cohort of head and neck SFTs sheds important light on several aspects of this disease, including a changing morphologic and anatomic range in the head and neck, with associated issues in the histopathologic differential diagnosis. Most importantly, however, this cohort provides sufficient experience with cases to allow useful observations regarding pathologic features associated with prognosis for SFTs at this site. Once again, the prognostic associations observed in this FIGURE 5 . A, Lipomatous differentiation was present in both classic SFTs (seen here) and cellular SFTs. B, SFTs with stromal giant cells as previously designated as GCA were infrequent. C, Myxoid change was seen in a subset, associated with microcystic change, and myxoid pools with pulmonary edema-like appearance (lower left). D, Stromal myxoid change, with concomitant lipomatous differentiation, had raised consideration of myxoid liposarcoma in a biopsy sample. cohort echo longstanding ideas about SFTs, only with uniquely differing applications in the setting of the head and neck surgery and surgical pathology.
First, regarding the morphologic and anatomic range of SFTs in the head and neck, our study confirms some prior findings and challenges others. Comparing our experience with perhaps the most comprehensive review of all published head and neck SFT cases as of 2010, sourced from the oral pathology literature, 32 overall, we confirmed a lack of proclivity for female or male patients and similar median age (52 y) and size (2.8 cm). In terms of anatomic range, however, our cohort confirmed our suspicion that inclusion of OFHs and GCAs in the SFT spectrum-as supported by nuclear STAT6 expression seen in all cases we studiedresults in a significant overall proportion (25%) of head and neck SFTs arising in the orbit compared to the 6% reported previously. 32 These findings establish the orbital primary site as nearly as frequent as the sinonasal tract (30%), a discordance we feel reflects more limited access to nonoral sites by oral pathologists and publication biases in an area previously dominated by case reports and small series.
The overall differential diagnosis of SFTs, given the variations in cellularity and stromal changes, is quite broad, encompassing a number of benign and malignant entities, and has been reviewed extensively elsewhere. 20, 33 Speaking to the more anatomically specific differential in the head and neck, during review of these tumors, especially myxoid, cystic, and lipomatous ones, 5,11,34 we saw raised diagnostic consideration of entities with significantly different treatments and prognoses from SFTs. For example, one tumor with extensive myxoid and lipomatous differentiation, had presented in consultation with a prior diagnosis of "myxoid neoplasm, favor sarcoma" with consideration of a diagnosis of a high-grade myxoid liposarcoma. Break-apart fluorescence in situ hybridization for the FUS locus had been performed (and was negative). While challenging on the original biopsy material, the resection demonstrated diagnostic features of SFT (and confirmatory STAT6 positivity), supporting the utility of this marker in this setting. Another example is that of the thyroid SFT identified in our review. While scattered case reports [35] [36] [37] and one smaller series 38 describe SFTs arising in the thyroid and its capsule, our experience of only one among 88 lesions studied confirms the rarity of this presentation. Awareness of our recent observation of positivity for PAX8 (and to a lesser extent, PAX2) in nearly a third of SFTs of diverse sites 39 is important. In the head and neck, PAX8 has become a workhorse marker for thyroid carcinomas, including anaplastic, 40 the latter consideration having been proposed for our thyroid case at preoperative aspiration. One additional case actually raised the unusual differential of an amyloidoma. 41 This exceptionally sclerotic and hypocellular SFT had been studied by Congo red (and was negative), though STAT6 was positive, as were diagnostic histologic features.
Most useful, to our mind, are the prognostic observations to be made from this cohort. The clinical FIGURE 6 . Prominent stromal hyalinization, in association with vessels and in the stroma, imparted the appearance of collagen rosettes (A) reminiscent of amianthoid fibers or keloidal collagen. In one case, this feature predominated (B), such that a nodular amyloidoma had entered the difbehavior of SFTs, generally, remains difficult to predict based on traditional histopathologic parameters, and much of the published literature regarding these lesions focuses on tumors with either HPC [42] [43] [44] or SFT 12, 21, 45 morphology. The large, recent cohort from Demicco et al, 46 describes a series of 110 cases, including both SFTs and HPCs, from a variety of anatomic sites, usefully including 12 from the head and neck. On the basis of review of their (entire) cohort, a model was proposed based on age, size, and mitotic index, for stratification of SFTs for overall risk of metastasis and death. They observed that small tumors with low mitotic rates were very unlikely to metastasize, while large tumors ( ≥ 15 cm) in patients 55 years of age and above with mitotic figures of ≥ 4 per 10 high power fields required close follow-up due to a high risk of metastasis and death from disease. 46 Although we routinely use the Demicco model in our practice for SFTs of other sites, we underscore that this model is of limited use, operationally, for head and neck SFTs. As an illustration of why this is the case, consider the relative rarity of metastases (6%) yet frequent local recurrences (36%) in our cohort as compared with much higher rates of metastases (26%) and lower rate of local recurrences (10%) in the overall Demicco cohort 46 (for that matter, head and neck SFT sizes rarely pass 5 cm, let alone 15 cm). In short, our experience suggests that the overall clinical outcome of head and neck SFTs is driven by recurrence, which is predominantly local.
Modeling, then, recurrence, on unconditional univariate analysis we found that atypia, size, mitotic rate, epithelioid morphology and necrosis were adverse prognostic factors for head and neck SFTs, closely echoing the classic criteria for malignancy in HPC proposed by Enzinger and Smith 42 (mitotic rate, size, hypercellularity, cellular pleomorphism, hemorrhage, and necrosis). Interestingly, size and mitotic rate cutoffs suggested by analysis of the interquartile range from 25th to 75th percentile also very closely approximated the originally proposed cutoffs, namely > 4 mitoses per 10 high power fields, and 5 cm. In a joint prognostic model it appears that both size and mitotic index remain jointly prognostic for recurrence. Thus, overall, we note that that the parameters of size and mitotic index, albeit with slightly different cutoffs, associated with risk of metastasis in prior SFT cohorts, 42, 46 actually are associated with local recurrence in the head and neck. Thus, we recommend careful assessment of these parameters for prospective assessment of head and neck SFTs, and in our ongoing clinical practice note their association with aggression.
One more disappointing potential prognostic parameter in the cohort was margin status: we observed overall a high rate of histologically positive margins (67%) that did not correlate with local recurrence. We speculate that this finding may relate to the unique aspects and challenges of head and neck surgery, and emphasize, as we have reported previously, 47 that overall margin status must be assessed with close surgical and pathologic correlation. Endoscopic resections may show SFT extending broadly to cauterized margins yet may be deemed operatively free based on 3-dimensional anatomy. Such is borne out in our data, where in tumors with both followup and interpretable margins, 17% with apparently negative margins recurred locally, while 52% with positive margins did not.
We acknowledge that compared to prior head and neck SFTs cohorts, the proportion of recurrent cases in our cohort is higher. Prior studies report recurrence in 2/ 13, 48 0/11, 32 1/12, 49 2/8, 50 or 2/29 51 head and neck SFTs, although these smaller series had predominantly shorter median follow-up. Even among a consecutive series of 9 histologically malignant solitary fibrous tumors of the head and neck reported by Yang et al 52 only 3 recurred, still less than the 36% we observed. In contrast, our data are more in keeping with the head and neck subset of the MD Anderson series reported by Demicco et al 46 (local recurrence in 3/12, metastasis in 2/12), with the caveat that both this cohort and ours may equally reflect referral center bias. Even so, we echo the observations of Demicco and colleagues regarding the need for long-term follow-up for these cases. We observed recurrences as late as 228, 130, and 120 months, a phenomenon that has been noted in head and neck SFTs previously 51 ; our median time to recurrence was 10 months.
In summary, our findings confirm that SFTs of the head and neck demonstrate the full morphologic spectrum of these tumors at other sites, recognizing an expanded anatomic range including many orbital examples related to reclassification of lesions as SFT. Several of these cases that presented diagnostic challenges underscore particular diagnostic difficulties in the head and neck, ranging from PAX8 positivity, to myxoid and lipomatous patterns, to densely sclerotic SFTs. Overall, SFTs of the head and neck have a substantial local recurrence rate, indeed exceeding that seen for SFTs at other sites, but only infrequent ones metastasize or cause death from disease. The high rate of local recurrence underscores the intermediate malignant potential of these tumors and the need for longterm follow-up. *Archival immunostains were reviewed and tabulated if interpretable for the markers listed, excepting UMHS cases where CD34 was performed on all cases with evaluable material (see the Methods section). STAT6 immunostains were performed at UMHS on all CSMC and VCUHS cases as well as a subset of UMHS cases for this study. UPMC cases with available material were stained for STAT6 as described. Additional IHC findings per evaluation of original archived immunostains.
-indicates none observed. 
